Neiberg de Alcantara Lima

Dr. Neiberg de Alcantara Lima

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2010 in International Immunopharmacology
Verified
Journal Article
Closed access
EVEdfranck Sousa Oliveira Vanderlei
Edfranck Sousa Oliveira Vanderlei
KPKharla Kharolyni Nobre Rabelo Patoilo
Kharla Kharolyni Nobre Rabelo Patoilo
NLNeiberg de Alcantara Lima
Neiberg de Alcantara Lima
ALAna Patrícia Souza Lima
Ana Patrícia Souza Lima
JRJosé Ariévilo Gurgel Rodrigues
José Ariévilo Gurgel Rodrigues
NBNorma M. B. Benevides
Norma M. B. Benevides

1 May 2020 in Journal of Infection
Verified
Journal Article
Closed access
RMRheanne Maravelas
Rheanne Maravelas
TMThomas Austin Melgar
Thomas Austin Melgar
DVDuncan Vos
Duncan Vos
NLNeiberg de Alcantara Lima
Neiberg de Alcantara Lima
SSSapna Sadarangani
Sapna Sadarangani

1 March 2013 in Travel Medicine and Infectious Disease
Verified
Journal Article
Closed access
RCRodrigo Barbosa Callado
Rodrigo Barbosa Callado
TCTassia Gabrielle Ponte Carneiro
Tassia Gabrielle Ponte Carneiro
CPCamille Carneiro da Cunha Parahyba
Camille Carneiro da Cunha Parahyba
NLNeiberg de Alcantara Lima
Neiberg de Alcantara Lima
GJGeraldo Silva Junior
Geraldo Silva Junior
EDElizabeth de Francesco Daher
Elizabeth de Francesco Daher

1 February 2012 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
PDF file
NLNeiberg de Alcantara Lima
Neiberg de Alcantara Lima
CVCarol C. Vasconcelos
Carol C. Vasconcelos
PFPedro Henrique O. Filgueira
Pedro Henrique O. Filgueira
MKMeissa Kretzmann
Meissa Kretzmann
TSTiciano A. S. Sindeaux
Ticiano A. S. Sindeaux
EDElizabeth F. Daher
Elizabeth F. Daher
Tuberculosis (TB) is a current public health problem, remaining the most common worldwide cause of mortality from infectious disease. Recent studies indicate that genitourinary TB is the third most common form of extra-pulmonary disease. The diagnosis of renal TB can be hypothesized in a non-specific bacterial cystitis associated with a therapeutic failure or a urinalysis with a persistent leukocyturia in the absence of bacteriuria. We report on the case of a 33-year-old man who presented on admission end stage renal disease (ESRD) secondary to renal TB and a past history of pulmonary TB with important radiologic findings. The diagnosis was based on clinical findings despite all cultures being negative. Empiric treatment with tuberculostatic drugs was started and the patient became stable. He was discharged with no symptom, but without renal function recovery. He is on maintenance hemodialysis three times a week. TB is an important cause of kidney disease and can lead to irreversible renal function loss.

1 June 2016 in Brazilian Dental Journal
Verified
Journal Article
Open access
PGPaula Goes
Paula Goes
NLNeiberg de Alcantara Lima
Neiberg de Alcantara Lima
JRJosé Ariévilo Gurgel Rodrigues
José Ariévilo Gurgel Rodrigues
NBNorma M. B. Benevides
Norma M. B. Benevides
GBGerly Brito
Gerly Brito
VLVilma Lima
Vilma Lima
The aim of this study was to evaluate the anti-inflammatory and anti-resorptive effect of atorvastatin (ATV) in an experimental alveolar bone loss (ABL) model. Wistar rats were subjected to ligature placement around the maxillary second molar for 11 days. The animals received 0.9% saline (2 mL/kg) or ATV (0.3, 3 or 27 mg/kg) daily by gavage. ABL was evaluated by resorption area and histopathological analysis. Serum bone-specific alkaline phosphatase (BALP) activity was also evaluated. Leukogram was performed at 0 h, 6th h, 2nd, 7th and 11th days. Kidney and liver conditions and the body mass variation were analyzed. ATV (3 and 27 mg/kg) inhibited ABL by 39% and 56%, respectively. Histopathological analysis showed that ATV 27 mg/kg prevented ABL and cemental resorption, and inflammatory cell infiltration induced by ligature. ATV (27 mg/kg) prevented serum BALP levels reduction. ATV (27 mg/kg) prevented leukocytosis and did not affect either kidney or liver function nor body mass weight. ATV showed a protecting effect in the ligature-induced periodontitis, without affecting system parameters, by inhibition of inflammatory process and by its anabolic activity on the alveolar bone.

19 October 2021 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
NLNeiberg de Alcantara Lima
Neiberg de Alcantara Lima
DMDavid T. Martin
David T. Martin
RCRicardo Lessa de Castro
Ricardo Lessa de Castro
ALAdam Ladzinski
Adam Ladzinski
ARAnya Ring
Anya Ring
TMThomas A. Melgar
Thomas A. Melgar
Chagas disease is caused by the parasitic flagellate protozoa Trypanosoma cruzi and can affect multiple organs, including the heart.1 In the United States, most patients with Chagas cardiomyopathy are immigrants from regions in Central and South America where the disease is endemic.2 In this cross-sectional study, we sought to describe patient characteristics and outcomes of patients hospitalized for Chagas cardiomyopathy in the United States and trends in the percentage of hospital discharges for Chagas cardiomyopathy.